telaprevir (Incivek)

Pharmacy Author:
Medical and Pharmacy Editor:

GENERIC NAME: telaprevir

BRAND NAME: Incivek (This drug was discontinued by the manufacturer, but will be available until October 2014)

DRUG CLASS AND MECHANISM: Telaprevir is a man-made antiviral medication that targets hepatitis C virus (HCV). Similar drugs include simeprevir (Olysio) and boceprevir (Victrelis). These drugs are called direct-acting antiviral agents because they act directly on hepatitis C virus. They block the replication of hepatitis C virus in human cells by binding to and inhibiting protease enzymes that HCV use for reproducing. Inhibiting viral replication reduces HCV viral load in the body to undetectable levels in some patients. The FDA approved Telaprevir in August 2011.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Tablets: 375 mg

STORAGE: Store telaprevir tablets between temperatures of 15 C 30 C (59 F 86 F).

PRESCRIBED FOR: Telaprevir is used for treating chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa (PegIntron) and ribavirin (Rebetol) in adults with compensated liver disease who have not been treated before or failed previous treatment.

Medically Reviewed by a Doctor on 8/27/2014



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index